Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration: A 12-month randomized prospective study

导出原文传递

翻译打印收藏纠错

作者： El-Mollayess,G.M. ^[1] ; Mahfoud,Z. ^[2] ; Schakal,A.R. ^[3] ; Salti,H.I. ; Jaafar,D. ; Bashshur,Z.F.

作者单位： Department of Ophthalmology, Hotel Dieu de France, St.Joseph University, Beirut, Lebanon ^[1] Department of Ophthalmology, American University of Beirut, Beirut, Lebanon ^[2] Department of Public Health, Weill Cornell Medical College, Doha, Qatar ^[3]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American Journal of Ophthalmology

2012年153卷3期

481-489页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration: A 12-month randomized prospective study

American Journal of Ophthalmology

相似文献

American Journal of Ophthalmology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration: A 12-month randomized prospective study

American Journal of Ophthalmology

相似文献

American Journal of Ophthalmology

相关期刊

检索历史清除